| Financial Year |
March 31 2022 |
| Monetary Funds |
196,465,502.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
96,911,277.95 |
| Accounts Receivable |
73,183,098.62 |
| Advances to Suppliers |
47,883,385.08 |
| Other Receivables |
161,261,925.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
14,366,750.02 |
| Dividend Receivable |
-- |
| Inventories |
1,050,172,441.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,033,165.39 |
| Total Current Assets |
1,627,910,795.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
81,704,647.10 |
| Investment Properties |
86,865,375.35 |
| Fixed Assetes |
2,448,348,497.64 |
| Under-construction Projects |
406,577,149.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,291,254.49 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,373,031.83 |
| Deferred Income Tax Assets |
2,231,950.35 |
| Other Non-Current Assets |
1,030,566,822.33 |
| Sub-Total of Non-Current Assets |
4,323,778,728.90 |
| Total Assets |
5,951,689,524.68 |
| Short-Term Loans |
894,766,159.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
175,566,186.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,049,618.73 |
| Taxes Payable |
78,689,455.63 |
| Interest Payable |
409,960,848.73 |
| Dividend Payable |
5,877,419.73 |
| Other payables |
1,530,043,554.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
343,881,758.76 |
| Other Current Liabilities |
3,134,190.99 |
| Sub-Total of Current Liabilities |
3,073,240,086.11 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,792,637,604.26 |
| Deferred Income Tax Liabilities |
888,197.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,803,020,809.88 |
| Total Liabilities |
6,876,260,895.99 |
| Paid-In Capital(Or Share Stock) |
1,205,476,595.00 |
| Capital Surplus |
4,752,300,901.35 |
| Surplus Reserve |
117,593,372.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,904,529,361.73 |
| Minority Stockholder's Interest |
976,670.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-925,548,041.60 |
| Owner's Equity（Stockholder's Equity） |
-924,571,371.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,951,689,524.68 |
